Scandinavian ChemoTech initiates a new long-term strategy for its two business areas
After a year full of success, the Company initiates its new strategy that clarifies the way forward for the Company's two business areas.Since 2020, the ChemoTech Group has been conducting two business areas, veterinary and human medicine, which, in addition to sharing the unique TSE[1] technology, have relatively different conditions. As a result, the Company has worked with an overall strategy during the year in order to optimise the clinical and commercial opportunities for each business area.
Vetiqure (Animal Care)
It is clear today that the Company's veterinary operations have at